Risk of Shareholder Value Dilution Through the Exercise of Stock Acquisition Rights
First written in FY2016. 18 of 38 entries say "Mitigated", first in FY2017-Q3. Latest entry: 2026-10-14.
CanBas moved to the "Worse" side of this theme in 2020, the same year as the typical company in this theme.
The whole theme swung hardest in 2018: 9 of 9 companies on the "Worse" side.
7 other companies' latest entry also says "Worsened".
- FY2026WorsenedAnnual report
「The total represented 0.5% of the Company's issued shares as of the end of the interim accounting period.」
The potential dilution ratio rose from 0.2% at the end of the previous fiscal year to 0.5%, increasing the potential for future dilution through 43,000 shares under the 21st series of stock acquisition rights. - FY2026-H1WorsenedAnnual report
「The total represented 0.5% of the Company's issued shares as of the end of the interim accounting period.」
The potential share ratio increased from 0.2% at the end of the previous fiscal year to 0.5%. In addition, the Company issued the 21st Series Stock Acquisition Rights underlying 43,000 common shares to 15 employees, expanding the potential for future dilution. - FY2025MitigatedAnnual report
「The total represented 0.2% of the Company's issued shares as of the fiscal year-end.」
The potential share ratio decreased substantially from 9.6% at the end of the previous fiscal year to 0.2%, reducing the potential for future dilution. The 19th and 20th Series Stock Acquisition Rights were exercised during the fiscal year, bringing the number of issued shares to 19,713,655. - FY2025-H1MitigatedAnnual report
「The total represented 3.4% of the Company's issued shares as of the end of the interim accounting period.」
The potential share ratio decreased from 9.6% at the end of the previous fiscal year to 3.4%, reducing the potential for future dilution. During the interim accounting period, 1,090,000 shares were issued through the exercise of stock acquisition rights. - FY2024RestatedAnnual report
「The total represented 9.6% of the Company's issued shares as of the fiscal year-end.」
The total number of potential shares to be issued was 9.6% of issued shares, reconfirming the potential for future dilution. - FY2024-Q3RestatedAnnual report
「The total represented 9.6% of the Company's issued shares as of the end of the third quarter accounting period. The Company may continue to implement similar incentive plans to secure talented personnel. It may also raise funds using stock acquisition rights.」
The potential share ratio was 9.6%, indicating the potential for future dilution remained at the same level as previously. The possibility of additional grants of stock acquisition rights and fundraising also remains. - FY2024-Q2MitigatedAnnual report
「The total represented 9.6% of the Company's issued shares as of the end of the second quarter accounting period.」
The potential share ratio decreased from 20.1% at the end of the previous fiscal year and 11.5% at the end of the previous quarter to 9.6%, reducing the potential for future dilution. - FY2024-Q1MitigatedAnnual report
「The total represented 11.5% of the Company's issued shares as of the end of the first quarter accounting period.」
The potential share ratio decreased from 20.1% at the end of the previous fiscal year to 11.5%, reducing the potential for future dilution. Meanwhile, 1,260,000 shares were delivered through the exercise of stock acquisition rights, and dilution from shares already issued is progressing. - FY2023WorsenedAnnual report
「The total represented 20.1% of the Company's issued shares as of the fiscal year-end.」
The potential share ratio increased from 0.9% in the immediately preceding quarter's filing to 20.1%. The issuance of the 19th and 20th Series Stock Acquisition Rights expanded the potential for future dilution of equity value. - FY2023-Q3RestatedAnnual report
「The total represented 0.9% of the Company's issued shares as of the end of the third quarter accounting period.」
The total number of potential shares to be issued was 0.9% of issued shares, reconfirming the potential for dilution at the same level as in the previous quarter. During the third quarter accounting period, stock acquisition rights underlying 29,500 shares were granted to 11 employees. - FY2023-Q2MitigatedAnnual report
「The total represented 0.9% of the Company's issued shares as of the end of the second quarter accounting period.」
The total number of potential shares to be issued decreased from 12.6% in FY2023-Q1 to 0.9%. Exercise and conversion of the 17th Series Stock Acquisition Rights and the 4th Series Convertible Bonds with Stock Acquisition Rights progressed substantially reducing the potential for future dilution, although dilution from shares already issued has occurred. - FY2023-Q1MitigatedAnnual report
「The total represented 12.6% of the Company's issued shares as of the end of the first quarter accounting period.」
The potential share ratio decreased from 38.6% at the end of FY2022 to 12.6%. The filing also stated that all outstanding 17th Series Stock Acquisition Rights had been exercised by the filing date, but the issuance of new shares has diluted existing shareholders. - FY2022MitigatedAnnual report
「The total represented 38.6% of the Company's issued shares as of the fiscal year-end.」
The potential share ratio decreased from 54.0% at the end of the third quarter to 38.6%. Meanwhile, the number of issued shares increased through the exercise of stock acquisition rights and other instruments, and dilution from shares already issued is progressing. - FY2022-Q3MitigatedAnnual report
「The total represented 54.0% of the Company's issued shares as of the end of the third quarter accounting period.」
The potential share ratio decreased from 79.6% at the end of the previous quarter to 54.0%, reducing the potential for future dilution. However, it remained equivalent to more than half of issued shares. - FY2022-Q2MitigatedAnnual report
「The total represented 79.6% of the Company's issued shares as of the end of the second quarter accounting period.」
The potential share ratio decreased from 92.2% at the end of the previous quarter to 79.6%. Meanwhile, 432,100 shares were delivered during the quarter through the exercise of stock acquisition rights, and dilution from shares already issued is progressing. - FY2022-Q1WorsenedAnnual report
「The total represented 92.2% of the Company's issued shares as of the end of the first quarter accounting period.」
The total number of potential shares to be issued increased to 92.2% of issued shares. The 17th Series Stock Acquisition Rights are underlying 5,555,400 shares, and 134,700 shares were issued during the quarter through the exercise of stock acquisition rights, increasing both the potential for future dilution and dilution from shares already issued. - FY2021WorsenedAnnual report
「The number of shares underlying the 17th Series Stock Acquisition Rights is 5,555,400 common shares of the Company.」
Although the potential share ratio decreased to 17.6% at the fiscal year-end, the issuance of the 17th Series Stock Acquisition Rights underlying 5,555,400 shares was approved after the filing, expanding the potential for additional dilution. - FY2021-Q3MitigatedAnnual report
「The total represented 26.3% of the Company's issued shares as of the end of the third quarter accounting period.」
The potential share ratio decreased to 26.3% from 20.5% at the end of the previous fiscal year and 40.2% at the end of the previous quarter, reducing the potential for future dilution from the previous quarter. Meanwhile, 801,300 shares were issued and ¥356 million was raised during the third quarter through the exercise of stock acquisition rights. - FY2021-Q2WorsenedAnnual report
「The total represented 40.2% of the Company's issued shares as of the end of the second quarter accounting period.」
The potential share ratio increased from 20.5% at the end of the previous fiscal year to 40.2%, substantially increasing the potential for future dilution. The 16th Series Stock Acquisition Rights are underlying 1,762,900 shares, and 252,800 shares were issued during the second quarter through the exercise of existing stock acquisition rights. - FY2021-Q1WorsenedAnnual report
「The total represented 20.2% of the Company's issued shares as of the end of the first quarter accounting period.」
The potential share ratio was 20.2% at the end of the first quarter, a modest decrease from 20.5% at the end of the previous fiscal year. Meanwhile, the issuance of the 16th Series Stock Acquisition Rights underlying 1,762,900 shares was approved after the filing date, expanding the potential for additional dilution. - FY2020MitigatedAnnual report
「The total represented 20.5% of the Company's issued shares as of the fiscal year-end.」
The potential share ratio decreased from 24.2% at the end of the previous quarter to 20.5%, resulting in a modest reduction in the potential for future dilution. However, the possibility of raising funds using stock acquisition rights remains. - FY2020-Q3WorsenedAnnual report
「As of the end of the third quarter accounting period, the Company had 6,834,040 issued shares. Against this, the total number of shares to be issued if the stock acquisition rights remaining at the end of the third quarter accounting period are exercised in the future, hereinafter referred to as "potential shares," was 1,651,582, equivalent to 24.2% of issued shares.」
Outstanding potential shares remained at 1,651,582, but their ratio to issued shares was revised from 19.5% at the end of the previous quarter to 24.2%, indicating an increase in the potential for future dilution. The Company also stated that it may continue to raise funds through incentive plans and stock acquisition rights. - FY2020-Q2WorsenedAnnual report
「As of the end of the second quarter accounting period, the Company had 6,834,040 issued shares. Against this, the total number of shares to be issued if the stock acquisition rights remaining at the end of the second quarter accounting period are exercised in the future, hereinafter referred to as "potential shares," was 1,651,582, equivalent to 19.5% of issued shares.」
Outstanding potential shares increased to 1,651,582, or 19.5% of issued shares, substantially expanding the potential for future dilution from 3.7% at the end of the previous fiscal year. The Company also stated that it may raise funds through stock acquisition rights and convertible bonds with stock acquisition rights. - FY2020-Q1RestatedAnnual report
「As of the end of the first quarter accounting period, the Company had 6,834,040 issued shares. Against this, the total number of shares to be issued if the stock acquisition rights remaining at the end of the first quarter accounting period are exercised in the future, hereinafter referred to as "potential shares," was 255,000, equivalent to 3.7% of issued shares.」
Outstanding potential shares were 255,000, or 3.7% of issued shares, indicating a potential for dilution at the same level as at the end of the previous fiscal year. The Company also stated that it may implement future incentive plans and raise funds using stock acquisition rights. - FY2019MitigatedAnnual report
「The total represented 3.7% of the Company's issued shares as of the end of the fiscal year.」
Potential shares represented 3.7% of issued shares at the fiscal year-end, indicating a substantial reduction in the potential for future dilution from 17.5% at the end of the previous quarter. The 950,000 shares underlying the 14th Series Stock Acquisition Rights and the 378,240 shares underlying the stock acquisition rights attached to the 2nd Series Unsecured Convertible Bonds with Stock Acquisition Rights were exercised during the fiscal year. - FY2019-Q3MitigatedAnnual report
「As of the end of the third quarter accounting period, the Company had 6,084,040 issued shares. Against this, the total number of shares to be issued if the stock acquisition rights remaining at the end of the third quarter accounting period are exercised in the future, hereinafter referred to as "potential shares," was 1,062,500, equivalent to 17.5% of issued shares.」
Although shares continued to be issued through the exercise of stock acquisition rights, outstanding potential shares decreased from 1,442,500 shares, or 25.5%, at the end of the previous quarter to 1,062,500 shares, or 17.5%, reducing the potential for future dilution. The shares already issued have diluted equity value. - FY2019-Q2MitigatedAnnual report
「As of the end of the second quarter accounting period, the Company had 5,655,800 issued shares. Against this, the total number of shares to be issued if the stock acquisition rights remaining at the end of the second quarter accounting period are exercised in the future, hereinafter referred to as "potential shares," was 1,442,500, equivalent to 25.5% of issued shares.」
Although shares continued to be issued through the exercise of stock acquisition rights, outstanding potential shares decreased from 1,492,500 shares, or 26.6%, at the end of the previous quarter to 1,442,500 shares, or 25.5%, resulting in a modest reduction in the potential for future dilution. - FY2019-Q1WorsenedAnnual report
「As of the end of the first quarter accounting period, the Company had 5,605,800 issued shares. Against this, the total number of shares to be issued if the stock acquisition rights remaining at the end of the first quarter accounting period are exercised in the future, hereinafter referred to as "potential shares," was 1,492,500, equivalent to 26.6% of issued shares.」
Outstanding potential shares increased to 1,492,500, or 26.6% of issued shares, substantially expanding the potential for future dilution from 5.7% at the end of the previous fiscal year. - FY2018WorsenedAnnual report
「Number of shares underlying these stock acquisition rights: 950,000 shares」
Potential shares stood at 312,500, or 5.7% of issued shares, at the fiscal year-end. After the fiscal year-end, the Company issued the 14th Series Stock Acquisition Rights underlying 950,000 shares, expanding the potential for additional dilution. - FY2018-Q3WorsenedAnnual report
「As of the end of the third quarter accounting period, the Company had 5,505,800 issued shares. Against this, the total number of shares to be issued if the stock acquisition rights remaining at the end of the third quarter accounting period are exercised in the future, hereinafter referred to as "potential shares," was 312,500, equivalent to 5.7% of issued shares.」
Outstanding potential shares increased from 192,000 shares, or 3.5%, at the end of the previous quarter to 312,500 shares, or 5.7%, expanding the potential for future dilution. The Company also stated that it may raise funds using stock acquisition rights. - FY2018-Q2MitigatedAnnual report
「As of the end of the second quarter accounting period, the Company had 5,505,800 issued shares. Against this, the total number of shares to be issued if the stock acquisition rights remaining at the end of the second quarter accounting period are exercised in the future, hereinafter referred to as "potential shares," was 192,000, equivalent to 3.5% of issued shares.」
Potential shares decreased from 254,500 shares, or 4.6%, at the end of the previous quarter to 192,000 shares, or 3.5%, further reducing the potential for future dilution. - FY2018-Q1MitigatedAnnual report
「As of the end of the first quarter, the company had 5,496,600 issued shares. Against this, the total number of shares scheduled to be issued if the stock acquisition rights remaining at the end of the first quarter are exercised in the future, referred to below as potential shares, was 254,500, equivalent to 4.6% of issued shares.」
Potential shares decreased from 450,500 shares, or 8.2%, at the end of the previous fiscal year to 254,500 shares, or 4.6%, further reducing the potential for future dilution. - FY2017MitigatedAnnual report
「As of the end of the fiscal year, the company had 5,494,600 issued shares. Against this, the total number of shares scheduled to be issued if the above stock acquisition rights are exercised in the future, referred to below as potential shares, was 450,500, equivalent to 8.2% of issued shares.」
The exercise of stock acquisition rights resulted in the issuance of 469,000 shares, reducing potential shares from 928,000, or 18.5%, previously to 450,500, or 8.2%. - FY2017-Q3MitigatedAnnual report
「As of the end of the third quarter, the company had 5,025,600 issued shares. Against this, the total number of shares scheduled to be issued if the stock acquisition rights remaining at the end of the third quarter are exercised in the future, referred to below as potential shares, was 923,000, equivalent to 18.4% of issued shares. The company may continue implementing similar incentive plans in the future to secure talented personnel.」
Potential shares declined modestly from 928,000 shares, or 18.5%, previously to 923,000 shares, or 18.4%, while the company stated that it may continue its incentive plans in the future. - FY2017-Q1RestatedAnnual report
「The total number of shares scheduled to be issued if the stock acquisition rights remaining at the end of the first quarter are exercised in the future, referred to below as potential shares, was 928,000, equivalent to 18.5% of issued shares. The company may continue implementing similar incentive plans in the future to secure talented personnel.」
The company reiterated that potential shares represented 18.5% and that it may continue granting stock acquisition rights for incentive purposes. - FY2016First statedAnnual report
「As of the end of the fiscal year, the company had 5,025,600 issued shares. Against this, the total number of shares scheduled to be issued if the above stock acquisition rights are exercised in the future, referred to below as potential shares, was 928,000, equivalent to 18.5% of issued shares.」
The company quantifies the potential dilution from the exercise of stock acquisition rights associated with fundraising and employee incentives.